Tags
- 2026
- 2033
- 3
- 9
- A
- Accumulation
- Acute
- Acute lymphoblastic leukemia
- Adaptation
- ADCC
- Adjustment
- Administration
- Adoptive cell transfer
- Advancement
- Advancements
- Advances
- Adverse
- Adverse effect
- Adverse event
- Adverse Events
- Adverse reactions
- Advice
- Agriculture in the United States
- AIM
- Aims
- Allotransplantation
- Alpha
- American Society of Clinical Oncology
- An
- Analysis
- Annual growth rate
- Antibody-dependent cell-mediated cytotoxicity
- Antigen
- Antigen receptor
- Antler
- Apoptosis
- Application
- Approaches
- Approved
- Armed
- Ascó
- Autotransplantation
- Based on
- B cell
- B-cell lymphoma
- Benefit
- Bilirubin
- Biology
- Blood
- Breakthrough
- Bypass
- Cancer
- Car
- Caribou
- Cars
- Car t-cell therapy
- Car-t therapy
- Caspase
- Caspase-9
- CD20
- CD34
- CDC
- Cell
- Cell death
- Cell membrane
- Cells
- Cell Therapy
- Cellular
- Cetuximab
- Challenges
- Characteristic
- Characterized
- Checked tone
- Checkpoint
- Chimera
- Chimeric antigen receptor
- Clinical
- Clinical endpoint
- Clinical Oncology
- Clinical trial
- Clinical Trials
- CMR
- Combination
- Comparable
- Complement-dependent cytotoxicity
- Complete
- Complex
- Concern
- Conclusion
- Considerable
- Considered
- Construction
- Continuity
- Convention
- Co-stimulation
- Coverage
- CRISPR
- CRR
- CRS
- Cure
- Cytokine
- Cytokine release
- Cytokine release syndrome
- Cytotoxicity
- Data
- Death
- Delivery
- Demonstration
- Derive
- Development
- Difficulty
- Dimer
- Directions
- Disclaimer
- Disease
- Domain
- Driven
- Drug
- Drugs
- Durability
- Durable
- Duration
- Editing
- Efficacy
- Elevation
- Elimination
- Emerging technologies
- Enabling
- Encode
- Engineering
- Enhance
- Epidermal growth factor
- Epidermis
- Epitope
- Escape
- Escape challenges
- Exogeny
- Express
- Expression
- Extracellular
- Factor
- FDA
- Focusing
- Following
- Food
- Food and Drug Administration
- Four
- Gene editing
- Generation
- Generations
- Grade
- Grade 2
- Grade 3
- Graft-versus-host disease
- Growth
- Growth factor
- Growth factor receptor
- Growth rate
- Hematology
- Heterogeneity
- Histocompatibility
- Histocompatibility complex
- Hodgkin
- Hodgkin lymphoma
- Homing
- Humans
- Immune
- Immune checkpoint
- Immunology
- Immunosuppression
- Improved
- Include
- Incorporation
- Induction
- Infiltration
- Informational
- Infusion
- Initial
- Initiation
- Innovation
- In situ
- Intensity
- Interference
- Introduction
- Investigation
- Killing
- Knocking
- Knockout
- Kymriah
- Lack
- Landscape
- Lasting
- latest
- Let Go
- Lethality
- Leukemia
- Limitation
- Limitations
- Lymphoblast
- Lymphoblastic leukemia
- Lymphoma
- Major histocompatibility complex
- Manage
- Manufacturing
- Market
- Meanwhile
- Mechanism
- Medical
- Medical advice
- Metabolism
- Method
- Methods
- MHC
- Microenvironment
- Modified
- Modulation
- Molecular engineering
- Molecular mechanisms
- Molecule
- Molecules
- Most
- Multiple myeloma
- Nature Reviews Drug Discovery
- Neoplasm
- Neurotoxicity
- New
- Next
- Next Generation
- No
- Non-Hodgkin lymphoma
- Note
- Novel
- Number
- Observation
- Obstacles
- Offering
- Oncology
- Only
- On/Off
- Opportunities
- Over
- Overcome
- Partial
- Pathway
- Patient
- Peripheral
- Peripheral T-cell lymphoma
- Persistence
- Pharmaceutical drug
- Phase
- Pipeline
- Platform
- Preliminary
- Producer
- Product
- Programmed
- Programmed cell death
- Programmed cell death protein 1
- Progression-free survival
- Projected
- Proportion
- Prospect
- Prospects
- Protein
- Ptcl
- Quality
- Rangefinder
- Reaction
- Receptor
- Redirected
- Reduce
- Reducing
- Reduction
- Reflection
- Registered
- Regulation
- Relapse
- Relief
- Remains
- Remission
- Require
- Research
- Researcher
- Residual
- Residual-current device
- Resistance
- Response rate
- Result
- Rev
- Risk
- Rituximab
- Safety
- Sale
- Sales
- Scalability
- Second Generation
- Settings
- Severity
- Shift
- Side Effects
- Signaling
- Simplification
- Sites
- Situ
- Six
- So-called
- Society of the United States
- Solid
- Source
- Sources
- Still
- Strategy
- Structure
- Studie
- Study skills
- Suboptimal
- Suicide
- Suicide gene
- Surface
- Surface protein
- Survival
- Switch
- Switches
- Symptom
- Syndrome
- Synthetic
- Synthetic biology
- Targeted
- T cell
- T-cell lymphoma
- T-cell receptor
- T-cell therapy
- TCR
- Technologie
- Technology
- Temporary
- Terminate
- The Knockout
- Therapeutic effects
- Therapy
- Therapy approaches
- The Shift
- The Tumor
- Three
- Three Days
- Tithe
- Toxicity
- Traditional
- Transport
- Treating
- Treatment of cancer
- Trial
- Trials
- Trigger
- Triggers
- Truck
- Trucks
- Truncation
- Tumor
- Tumor microenvironment
- Tumors of the hematopoietic and lymphoid tissues
- Universal
- Universality
- Via
- What
- Widespread